Abstract
Objectives Multiple machine learning-based visual and auditory digital markers have demonstrated associations between Major Depressive Disorder (MDD) status and severity. The current study examines if such measurements can quantify response to antidepressant treatment (ADT) with selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine uptake inhibitors (SNRIs).
Methods Visual and auditory markers were acquired through an automated smartphone task that measures facial, vocal, and head movement characteristics across four weeks of treatment (with timepoints at baseline, 2 weeks, and 4 weeks) on ADT (n = 12). The Montgomery-Asberg Depression Rating Scale (MADRS) was collected concordantly through clinical interviews to confirm diagnosis and assess changes in MDD severity.
Results Patient responses to ADT demonstrated clinically and statistically significant changes in the MADRS F(2,34) = 51.62, p <.0001. Additionally, patients demonstrated significant increases in multiple digital markers including facial expressivity, head movement, and amount of speech. Finally, patients demonstrated significant decreased frequency of fear and anger facial expressions.
Conclusion Digital markers associated with MDD demonstrate validity as measures of treatment response.
Competing Interest Statement
Isaac R. Galatzer-Levy, Anzar Abbas, Vidya Koesmahargyo, and Vijay Yadav are employees of AiCure, LLC and hold stock options in AiCure, LLC. Colin Sauder is an employee of Karuna Therapeutics.
Funding Statement
Funding and staff resources for this study was jointly provided by AiCure, LLC and Adams Clinical.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Integreview
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All code used to calculate visual and auditory markers of MDD, the resulting data output, and the executable python script for the analysis of the data output presented in this manuscript is publicly available on Github.
